跳至主要内容
临床试验/NCT07430852
NCT07430852尚未招募不适用

Genetic and Environmental Contributions to Obesity Pathogenesis

University of Washington1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2026年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
110
试验地点
1
主要终点
Study 1: Hypothalamic Gliosis

研究概览

简要总结

The goal of this research is to investigate genetic and environmental factors that contribute to obesity through brain inflammation. The main questions are 1) if identical twins, who differ in food consumption habits, have differences in adiposity markers and brain inflammation and 2) if signs of brain inflammation in response to a specific diet is modified by genetics.

详细描述

In study 1, participant twin pairs that differ in habitual diet intake, will complete an in-person study visit that includes an MRI of the brain and abdomen, body composition measurement, a blood draw and questionnaires. In study 2, a different set of participant twin pairs will complete 3 in-person study visits over 2 weeks, during which all meals will be provided by the study. Visits will include brain MRI, body composition measurements, blood draws and questionnaires.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 20-45 years
  • Differs in habitual diet from co-twin (study 1).
  • Willing to undergo 7-day overfeeding and hypocaloric feeding periods (study 2)
  • Member of the Washington State Twin Registry

排除标准

  • History of bariatric surgery or active participation in weight-loss program
  • Major medical or neurological disorder (e.g., diabetes, multiple sclerosis)
  • Known gallbladder disease, anemia, impaired thyroid, kidney or liver function or hypertriglyceridemia (>350 mg/dl) (study 2)
  • Current use of weight-loss medications or other medications known to alter appetite (e.g., atypical anti-psychotics)
  • High levels of vigorous physical activity (>300 min./week)
  • Pregnancy, menopause, or breastfeeding
  • Individuals with severe food allergies and dietary restrictions (e.g., vegan/vegetarian, gluten-free, others) (study 2)
  • Co-twin unwilling or unable to participate
  • MRI contraindication (e.g., implanted metal, claustrophobia)
  • Lifetime eating disorder
  • Current smoking or heavy alcohol use (≥ 2 drinks per day for females and ≥ 3 drinks per day for males)
  • BMI > 45 kg/m2 (study 1)
  • BMI > 35 kg/m2 (study 2)
  • Weight > 350 pounds or determined to be safe by MRI tech (MRI limit)
  • Inability to participate in a controlled diet program (study 2) or undergo other study procedures
  • Non-English speaking-or-reading individuals

研究组 & 干预措施

Study 1, A co-twin control study of habitual diet

No Intervention

Monozygotic twin pairs with differential habitual diet practices will undergo measurements including body composition, and MRI measures of hepatic adiposity and neuroinflammation.

Study 2, A twin study of controlled diet

Experimental

Monozygotic twin pairs will be provided an assigned diet for 14-days.

干预措施: Diet modification (Behavioral)

结局指标

主要结局

Study 1: Hypothalamic Gliosis

时间窗: at enrollment

T2 relaxation time as measured by brain MRI

Study 2: Hypothalamic Gliosis

时间窗: 7 days of diet intervention

T2 relaxation time as measured by brain MRI

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ellen Schur, MD, MS

Professor: School of Medicine

University of Washington

研究点 (1)

Loading locations...

相似试验